Uncovr, a French surgical artificial intelligence startup, has closed a $7 million seed funding round to accelerate the development of AI infrastructure designed specifically for surgical environments.
The funding round was led by Index Ventures, with participation from Seedcamp, Frst, No Label Ventures, and Entrepreneurs First. This marks the company’s first institutional capital injection since its founding in 2025.
Advancing Surgical AI Infrastructure
Uncovr plans to deploy the fresh capital across three primary areas: continued product development, geographic expansion of hospital deployments, and further refinement of its AI models. The company’s focus on surgical applications positions it within the broader healthtech sector, where artificial intelligence is increasingly being integrated into clinical workflows to enhance precision and outcomes.
The startup’s emphasis on developing AI infrastructure tailored to operating rooms reflects growing interest in how machine learning can be adapted for high-stakes medical environments. Surgery presents unique technical challenges—from real-time decision support to integration with existing hospital systems—that differ significantly from other healthcare applications.
Building Momentum in European Healthtech
The backing from this diverse syndicate of European investors underscores confidence in Uncovr’s approach. Index Ventures, known for backing deep-tech and healthcare ventures across Europe, leads the round, while the participation of early-stage focused funds like Seedcamp and Entrepreneurs First suggests investor confidence in the founding team’s execution capabilities.
Uncovr enters a competitive but expanding market for surgical technology. European healthtech has attracted significant venture capital in recent years, with investors increasingly backing companies developing AI solutions for clinical applications. The sector has matured beyond initial proof-of-concept phases, with hospitals now more willing to pilot and deploy new technologies that demonstrate clear clinical value.
The company’s focus on hospital deployments as a near-term milestone indicates a pragmatic approach to commercialization. Rather than pursuing lengthy regulatory pathways immediately, Uncovr appears positioned to generate real-world usage data and clinical feedback that could inform future scaling and regulatory strategies.
European Startup Ecosystem Context
France has established itself as a meaningful hub for healthtech innovation within Europe, building on strengths in medical research and a supportive regulatory environment. Uncovr’s funding reflects the continued capacity of European venture capital to back specialized deep-tech companies tackling complex problems in regulated industries.
The $7 million seed round places Uncovr among the better-capitalized European surgical AI startups, providing runway for meaningful product development and market validation. As healthcare systems across Europe increasingly adopt digital tools and AI solutions, startups addressing specific clinical use cases like surgical support stand to benefit from both institutional demand and regulatory momentum around digital health innovation.